The findings revealed that the TXA drug can reduce the risk of death for those who suffer a mild or moderate traumatic brain injury.
Peter McCabe, Chief Executive of Headway, said: “Every three minutes someone in the UK is admitted to hospital with a head injury so it is encouraging to hear the findings of this study and the potential for TXA to help people.
“While this study does not demonstrate lives will be saved following severe brain injury, we know that patients with mild to moderate brain injuries can suffer complications where TXA may be beneficial.
“It’s also important to recognise that improvements in acute care have to be match by investment in rehabilitation. Put simply, a life worth saving has to be a life worth living.”Back